Candida albicans abrogates the expression of interferon-γ-inducible protein-10 in human keratinocytes

FEMS Immunology and Medical Microbiology

Volumn 54, Issue 1, 2008, Pages 122-128

  Shiraki, Yumi ^b   Ishibashi, Yoshio ^a   Hiruma, Masataro ^b   Nishikawa, Akemi ^a   Ikeda, Shigaku ^b  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

Candida albicans; Chemokine; IP 10; Keratinocyte

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; GAMMA INTERFERON INDUCIBLE PROTEIN 10; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2;

ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CANDIDA ALBICANS; CELLS, CULTURED; CHEMOKINE CXCL10; DINOPROSTONE; DOWN-REGULATION; HUMANS; INTERFERON TYPE II; KERATINOCYTES; RNA, MESSENGER;

EID: 51349152700     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2008.00457.x     Document Type: Article

References (35)

1. Albanesi C, Scarponi C, Sebastiani S, Cavani A, Federici M, Sozzani S Girolomoni G (2001) A cytokine-to-chemokine axis between T lymphocytes and keratinocytes can favor Th1 cell accumulation in chronic inflammatory skin diseases. J Leukoc Biol 70: 617 623.
2. Alem MA Douglas LJ (2005) Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol 54: 1001 1005.
3. Aronoff DM, Canetti C Peters-Golden M (2004) Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J Immunol 173: 559 565.
4. Betz M Fox BS (1991) Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 146: 108 113.
5. Boorsma DM, Flier J, Sampat S, Ottevanger C, de Haan P, Hooft L, Willemze R, Tensen CP Stoof TJ (1998) Chemokine IP-10 expression in cultured human keratinocytes. Arch Dermatol Res 290: 335 341.
6. Deva R, Ciccoli R, Schewe T, Kock JL Nigam S (2000) Arachidonic acid stimulates cell growth and forms a novel oxygenated metabolite in Candida albicans. Biochim Biophys Acta 1486: 299 311.
7. Dhillon NK, Peng F, Ransohoff RM Buch S (2007) PDGF synergistically enhances IFN-gamma-induced expression of CXCL10 in blood-derived macrophages: implications for HIV dementia. J Immunol 179: 2722 2730.
8. Erb-Downward JR Noverr MC (2007) Characterization of prostaglandin E2 production by Candida albicans. Infect Immun 75: 3498 3505.
9. Ghannoum MA (2000) Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 13: 122 143.
10. Hamajima K, Nishikawa A, Shinoda T Fukazawa Y (1988) Detection of specificity of a new antigen in Candida tropicalis and its evaluation by taxonomic DNA analyses. Microbiol Immunol 32: 1013 1024.
11. Hay RJ (1999) The management of superficial candidiasis. J Am Acad Dermatol 40: S35 S42.
12. Kaliński P, Hilkens CM, Snijders A, Snijdewint FG Kapsenberg ML (1997) IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 159: 28 35.
13. Kanda N Watanabe S (2002) Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431. J Invest Dermatol 119: 1080 1089.
14. Kaplan G, Luster AD, Hancock G Cohn ZA (1987) The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin. J Exp Med 166: 1098 1108.
15. Kay LJ, Yeo WW Peachell PT (2006) Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation. Br J Pharmacol 147: 707 713.
16. Mays SR, Bogle MA Bodey GP (2006) Cutaneous fungal infections in the oncology patient: recognition and management. Am J Clin Dermatol 7: 31 43.
17. Montagnoli C, Sandini S, Bacci A, Romani L La Valle R (2004) Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis. Med Mycol 42: 319 324.
18. Nishikawa A, Sekine T, Ikeda R, Shinoda T Fukazawa Y (1990) Reassessment of antigenic determinant of Saccharomyces cerevisiae serotype Ia. Microbiol Immunol 34: 825 840.
19. Noverr MC, Phare SM, Toews GB, Coffey MJ Huffnagle GB (2001) Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect Immun 69: 2957 2963.
20. Noverr MC, Toews GB Huffnagle GB (2002) Production of prostaglandins and leukotrienes by pathogenic fungi. Infect Immun 70: 400 402.
21. Ogawa H, Summerbell RC, Clemons KV, Koga T, Ran YP, Rashid A, Sohnle PG, Stevens DA Tsuboi R (1998) Dermatophytes and host defence in cutaneous mycoses. Med Mycol 36: 166 173.
22. Porcaro I, Vidal M, Jouvert S, Stahl PD Giaimis J (2003) Mannose receptor contribution to Candida albicans phagocytosis by murine E-clone J774 macrophages. J Leukoc Biol 74: 206 215.
23. Profita M, Sala A, Bonanno A et al 2003) Increased prostaglandin E2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia. J Allergy Clin Immunol 112: 709 716.
24. Romagnoli G, Nisini R, Chiani P, Mariotti S, Teloni R, Cassone A Torosantucci A (2004) The interaction of human dendritic cells with yeast and germ-tube forms of Candida albicans leads to efficient fungal processing, dendritic cell maturation, and acquisition of a Th1 response-promoting function. J Leukoc Biol 75: 117 126.
25. Romani L (2000) Innate and adaptive immunity in Candida albicans infections and saprophytism. J Leukoc Biol 68: 175 179.
26. Santoni G, Boccanera M, Adriani D, Lucciarini R, Amantini C, Morrone S, Cassone A De Bernardis F (2002) Immune cell-mediated protection against vaginal candidiasis: evidence for a major role of vaginal CD4+ T cells and possible participation of other local lymphocyte effectors. Infect Immun 70: 4791 4797.
27. Sato T, Iwabuchi K, Nagaoka I et al 2006) Induction of human neutrophil chemotaxis by Candida albicans-derived beta-1,6-long glycoside side-chain-branched beta-glucan. J Leukoc Biol 80: 204 211.
28. Schaller M, Mailhammer R Korting HC (2002) Cytokine expression induced by Candida albicans in a model of cutaneous candidosis based on reconstituted human epidermis. J Med Microbiol 51: 672 676.
29. Segal E (2005) Candida, still number one-what do we know and where are we going from there? Mycoses 48: 3 11.
30. Shapiro AC, Wu D Meydani SN (1993) Eicosanoids derived from arachidonic and eicosapentaenoic acids inhibit T cell proliferative response. Prostaglandins 45: 229 240.
31. Shiraki Y, Ishibashi Y, Hiruma M, Nishikawa A Ikeda S (2006) Cytokine secretion profiles of human keratinocytes during Trichophyton tonsurans and Arthroderma benhamiae infections. J Med Microbiol 55: 1175 1185.
32. Sugimoto Y Narumiya S (2007) Prostaglandin E receptors. J Biol Chem 282: 11613 11617.
33. Tüzün Y, Antonov M, Dolar N Wolf R (2007) Keratinocyte cytokine and chemokine receptors. Dermatol Clin 25: 467 476.
34. van der Pouw Kraan TC, Boeije LC, Smeenk RJ, Wijdenes J Aarden LA (1995) Prostaglandin E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 181: 775 779.
35. Zuber TJ Baddam K (2001) Superficial fungal infection of the skin. Where and how it appears help determine therapy. Postgrad Med 109: 117 120.